Insider buying last 90 days
No open-market insider purchases were filed for RYAN in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every RYAN insider filing, plotted on the chart in Gekko.Open RYAN in Gekko
NYSE: RYAN
Ryan Specialty (RYAN) Stock Analysis & Forecast
Sep 28 close
$38.12+0.23 (+0.6%)
Gekko Brief
AI summaryRyan Specialty shares have drawn attention this week following a three-month rally of 9%, attributed to index inclusion, a Q2 earnings beat, higher margin guidance and capital returns. A separate piece flagged a 4.0% single-day drop to $38.44, framing the stock as undervalued relative to fair value estimates. Both items concern the same underlying story: a period of volatility layered on top of recent operational strength.
The stock closed at $38.12, up 0.6%, sitting between its 50-day average of $41.72 and 200-day average of $40.40, reflecting a mixed trend. Over the past month shares are down 12.4%, though the six-month return remains positive at 20.1%. The GekkoIndex reads 66.5, placing RYAN in the Accumulation zone. Price sits 15.8% below Gekko Fair Value of $45.29.
The next earnings date falls on 29 October 2026, after the close, which is 30 days out and beyond a typical 20-trading-day hold. The prior report showed EPS of $0.47 against a $0.43 estimate, though shares still reacted with a 12.6% move. No insider, Congress or unusual options activity appears in the current window. Seasonality over the past 5 years shows an average 20-day return of 1.5% from this point in the calendar, positive in 3 of those years. Analyst coverage from 14 firms shows a consensus target of $50.53, with 8 buy ratings, 5 hold and 1 sell.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Ryan Specialty price vs fair value
Close $38.12200-day averageGekko Fair Value $45.29
Ryan Specialty quick facts
- Market cap
- $4.94B
- P/E ratio
- 49
- Forward P/E
- 14.6
- EPS, TTM
- $0.75
- Revenue, TTM
- $3.16B
- Profit margin
- 3.1%
- Dividend yield
- 1.38%
- Beta
- 0.56
- Volume
- 1.70M avg 2.17M
- 1-year return
- −30.1%
- Typical daily move
- ±4.4%
- Typical 20-day move
- ±5.8%
- 50-day average
- $41.72
- 200-day average
- $40.40
- Next earnings
- Oct 29 after close
- Shares outstanding
- 122.1M
Ryan Specialty swing-trade checklist
Ryan Specialty scores 4 supportive, 1 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed0 headwinds
- Trendmixed
Averages disagree
Close $38.12 sits between the 50-day ($41.72) and 200-day ($40.40) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
66.5, Accumulation
Reading 66.5 is in the Accumulation zone.
See the GekkoIndex - Fair valuesupportive
15.8% below
Price is 15.8% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Oct 29, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+1.5% on average
From this point in the calendar, the next 20 trading days averaged +1.5% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Ryan Specialty stock chart and price history
Ryan Specialty closed at $38.12 on Sep 28, 2026, −30.1% over the past year, inside a 52-week range of $29.28 to $59.19.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −12.4%
- 3 months
- −2.6%
- 6 months
- +20.1%
- 1 year
- −30.1%
The full RYAN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open RYAN in Gekko
Follow Ryan Specialty through every session
Put RYAN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track RYAN in GekkoFree for 7 days. No credit card required.
About Ryan Specialty
Ryan Specialty works with insurance brokers, agents, and carriers, giving them access to specialized coverage and the support needed to bring it to market. Its offerings cover distribution, underwriting, product creation, administrative handling, and risk management, and the firm is particularly known for acting both as a wholesale broker and as a managing underwriter.
These two roles form the backbone of how the company operates: placing specialized policies on behalf of brokers and agents while also taking on underwriting responsibilities for carriers. The people and firms it serves are insurance brokers, agents, and carriers who turn to it for this combination of distribution and underwriting support rather than a single isolated service.
Founded in 2010, Ryan Specialty is based in Chicago, Illinois. Its stock trades on the NYSE under the ticker RYAN.
- Listed
- NYSE
- Sector
- Finance
- Industry
- Insurance brokers/Services
- Website
- ryanspecialty.com
Ryan Specialty GekkoIndex: the smart money zone
Ryan Specialty’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 66.5, in the Accumulation zone, up 1.6 points over five sessions.
66.5Accumulation
Up 1.6 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 49 | +0.6% | +2.5% | ||
| Accumulation (current zone) | 219 | −0.5% | −2.4% | ||
| Neutral | 354 | +0.1% | +1.5% | ||
| Distribution | 46 | +1.1% | −0.3% | ||
| Selling | 4 | Too few readings yet | |||
Average RYAN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the RYAN price, zone by zone.Track RYAN in Gekko
Is Ryan Specialty stock overvalued? Gekko Fair Value
Ryan Specialty trades 15.8% below Gekko Fair Value of $45.29, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Ryan Specialty shares are worth, recalculated every trading day.
$45.29
Gekko Fair Value, Sep 26, 2026
15.8% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open RYAN in Gekko
Ryan Specialty insider and Congress trading
No open-market insider purchases were filed for Ryan Specialty, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in RYAN were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for RYAN, plotted on the chart in Gekko.Open RYAN in Gekko
Buybacks
Ryan Specialty has been buying back its own shares.
- Latest authorization
- $300.0M, Jul 30, 2026
- Bought back, quarter ended Jun 30, 2026
- $260.2M
- As a share of market cap
- 5.27%
- Trailing four quarters
- $303.7M
From company filings.
Hedge funds and billionaires quarter ended Dec 31
0of the funds Gekko tracks hold RYAN.
0added0opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Ryan Specialty earnings: next date and track record
Ryan Specialty reports on Oct 29, 2026, after the close (30 days away), and beat the EPS estimate in 3 of its last 8 reports.
Next earnings report
Oct 29, 2026
Expected after the close, 30 days away
- EPS estimate
- $0.49
- Revenue estimate
- $799.1M
3 of 8reports beat the EPS estimate
±7.4%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Apr 30, 2026 AI summary
- What they said
- Ryan Specialty reported Q1 2026 total revenue growth of 15%, with organic revenue growth of 11.8%. Adjusted EBITDAC grew 15.7% to $232 million with margin expansion of 10 basis points to 29.2%. Adjusted EPS grew 20% year-over-year to $0.47. The company repurchased $40 million of stock and highlighted strategic initiatives including Ryan Re approaching $2 billion in premium and launch of alternative capital sidecar RAC Re.
- Guidance
- Management flagged volatile and reactive insurance market conditions creating headwinds, particularly in wholesale brokerage where more tempered growth is now expected. No specific revenue or earnings targets were provided in the excerpt.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 30, 2026 | $0.47 est $0.43 | $795.2M est $781.4M | −12.6% |
| Feb 12, 2026 | $0.45 est $0.49 | $751.2M est $777.1M | −10.1% |
| Oct 30, 2025 | $0.47 est $0.47 | $754.6M est $777.4M | +7.7% |
| Jul 31, 2025 | $0.66 est $0.65 | $855.2M est $745.7M | −3.8% |
| May 1, 2025 | $0.39 est $0.39 | $690.2M est $679.8M | +2.1% |
| Feb 20, 2025 | $0.45 est $0.45 | $663.5M est $658.4M | −5.8% |
| Oct 30, 2024 | $0.41 est $0.42 | $604.7M est $602.0M | −5.9% |
| Aug 1, 2024 | $0.58 est $0.56 | $701.9M est $695.6M | +11.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Ryan Specialty stock forecast and analyst price targets
Analysts’ average 12-month price target for Ryan Specialty is $50.53, +32.6% from the last close, from 14 firms rating the stock in the last 90 days.
$50.53consensus 12-month target, +32.6% from the last close
Now $38.12Avg $50.53
Low $41High $55
Each firm’s latest rating in the last 90 days: 14 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 16 | Mizuho Securities | $43 | +12.8% |
| Aug 18 | Morgan Stanley | $48 | +25.9% |
| Aug 3 | Cantor Fitzgerald | $41 | +7.6% |
| Aug 3 | Morgan Stanley | $48 | +25.9% |
| Aug 3 | UBS | $55 | +44.3% |
−2.4%average 20-day move after past Accumulation readings
+1.5%average move over the next 20 trading days in the last 5 years
±4.4%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Ryan Specialty seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Ryan Specialty averaged +1.5% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.3% | 5 of 5 |
| Next 10 trading days | +2.9% | 3 of 5 |
| Next 15 trading days | +1.5% | 3 of 5 |
| Next 20 trading days | +1.5% | 3 of 5 |
| Next 30 trading days | +4.5% | 4 of 5 |
For scale, RYAN’s typical 20-trading-day move in either direction is about 5.8%.
Ryan Specialty market cap and key statistics
Ryan Specialty’s market cap is $4.94B, with a P/E ratio of 49 and revenue of $3.16B over the last twelve months.
Valuation
- Market cap
- $4.94B
- P/E ratio
- 49
- Forward P/E
- 14.6
- EPS, TTM
- $0.75
- Gekko Fair Value
- $45.29
Trading
- Volume
- 1.70M
- Avg volume, 20 days
- 2.17M
- 52-week high
- $59.19
- 52-week low
- $29.28
- Shares outstanding
- 122.1M
Financials
- Revenue, TTM
- $3.16B
- Profit margin
- 3.1%
- Return on equity
- 22.1%
- Quarterly earnings growth, YoY
- −14.3%
Risk and income
- Beta
- 0.56
- Typical daily move
- ±4.4%
- Typical 20-day move
- ±5.8%
- Dividend yield
- 1.38%
Ryan Specialty stock news this week
2 headlines about Ryan Specialty from the past week, newest first, each linking to the publisher.
- Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?Zacks Investment Research, Sep 23
- Is Ryan Specialty Holdings Inc (RYAN) a Bargain After 4.0% Drop? GF Value Says UndervaluedGuruFocus, Sep 22
Ryan Specialty peers
Ryan Specialty’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MRSHMarsh | Buying | 12.7% below |
| AJGArthur J. Gallagher | Accumulation | 13.9% below |
| AONAon | Buying | 23.4% below |
| WTWWillis Towers Watson | Buying | 15.5% below |
| BROBrown & Brown | Buying | 16.7% below |
| CRVLCorVel | Neutral | 10.7% above |
A peer links to its own page where one exists.
Ryan Specialty stock FAQ
What is Ryan Specialty’s market cap?
Ryan Specialty’s market cap is $4.94B at the Sep 28, 2026 close of $38.12, with 122.1M shares outstanding. The shares trade on a P/E ratio of 49.
What is the Ryan Specialty stock forecast?
The consensus analyst 12-month price target for Ryan Specialty is $50.53, +32.6% from the last close. Of the 14 firms that rated the stock in the last 90 days, 8 rate it a buy, 5 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.
Is Ryan Specialty stock overvalued or undervalued?
On Gekko’s estimate Ryan Specialty is undervalued: the Sep 28, 2026 close of $38.12 is 15.8% below Gekko Fair Value of $45.29. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Ryan Specialty report earnings next?
Ryan Specialty is expected to report on Oct 29, 2026, after the market closes (30 days away). Analysts expect earnings of $0.49 per share on revenue of $799.1M. Ryan Specialty beat the earnings estimate in 3 of its last 8 reports, moving 7.4% on average across the report.
What is Ryan Specialty’s 52-week high and low?
Ryan Specialty’s 52-week high is $59.19 and its 52-week low is $29.28; it closed at $38.12 on Sep 28, 2026, −30.1% over the past year. Over the last five years the shares peaked at $77.16 on Apr 3, 2025.
Is Ryan Specialty stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 5 items with data read as supportive (gekkoindex, fair value, earnings risk and seasonality), 1 as mixed (trend). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Ryan Specialty the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.